Will Nvidia Stock Keep Surging on China Optimism Or is the Cerebras IPO a New Risk?

Nvidia’s China outlook is improving as investors view reported H200 chip sales approvals and Jensen Huang’s Beijing trade discussions as signs U.S.-China semiconductor tensions may be stabilizing. That could preserve billions in future revenue and support continued AI spending, though Cerebras’ blockbuster IPO adds a new competitive variable in AI inference. CBRS surged nearly 70% on Thursday to above $300, highlighting rising investor appetite for alternatives to Nvidia’s GPU dominance.

Analysis

The market is starting to price Nvidia less like a pure U.S. hyperscaler beneficiary and more like a geopolitically optional franchise with multiple monetization paths. Partial China access, even if tightly capped, matters disproportionately because it improves utilization of the installed CUDA ecosystem and supports a premium multiple by reducing the probability of a hard terminal market share loss in a strategic region. The second-order effect is that Nvidia’s bear case shifts from “lost China revenue” to “China dilution of mix,” which is a much less damaging narrative for valuation.

Cerebras is more important as a signal than as an immediate earnings threat. The IPO gives investors a public-market benchmark for a non-GPU architecture, which can catalyze spending tests by large inference buyers who are dissatisfied with latency, power, and cluster complexity. That said, architectural alternatives usually bite first at the margins of inference economics, not at training scale, so the near-term revenue pool at risk is narrower than the headline implies; the real pressure shows up over 12-24 months if enterprise and sovereign buyers decide inference workloads can be decomposed away from NVIDIA’s stack.

Consensus is likely underestimating how both stories can be true at once: Nvidia can gain on China stabilization while facing creeping competitive erosion in inference. The most important watch item is not whether Cerebras wins share immediately, but whether its IPO legitimizes procurement experimentation across cloud, defense, and regulated industries. If that experimentation spreads, Nvidia’s growth rate can stay high while multiple expansion becomes harder because investors will begin discounting a modest but persistent mix of non-GPU alternatives.

The reversal risk is political, not technical. A headline setback in U.S.-China trade could quickly re-open the China overhang and compress sentiment in days, while a string of high-profile inference benchmarks or production wins for Cerebras could pressure the stock over months by forcing hyperscalers to hedge vendor concentration. In that environment, the market could simultaneously reward Nvidia on supply-chain relief and punish it on competitive optionality, making relative positioning more attractive than outright directional exposure.

Key Decisions for Investors

• Stay long NVDA, but use call spreads rather than cash equity for the next 1-2 quarters; the China optionality supports upside, while multiple compression from competitive noise caps convexity. Best risk/reward is 3-6 month upside participation with defined downside.
• Pair trade: long NVDA / short a basket of AI hardware challengers on strength in CBRS-related enthusiasm. The trade expresses that public-market discovery will likely help validate the category, but Nvidia still owns the software moat and distribution.
• Buy NVDA downside protection via 1-2 month puts into any China-trade headline rally. The geopolitical overhang can reprice quickly, and implied vol is likely cheaper than the tail risk of export-control reversal.
• Watch for any disclosed inference customer wins by CBRS; if repeated enterprise deployments emerge, rotate to a relative short NVDA vs long AMZN or MSFT only if cloud capex shifts toward multi-vendor inference. Until then, competition is a valuation issue, not an earnings issue.
• For event-driven accounts, consider a small long CBRS / short NVDA pair only after post-IPO liquidity normalizes. The trade is higher beta and should be sized as a tactical hedge against the market overpricing Nvidia’s monopoly status.